Martha Moore, MD
Family Medicine · Livingston, TNNPI 1336127513
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Novo Nordisk at 34.0% of the total. Reporting peaked in 2019 at $345 and has fallen 87.9% since, to $42 in 2022.
Across 58 payments — averaging $16.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$323
- Abbott$101
- Novartis$68
- Amarin Pharma, Inc.$63
- GSK$61
- Astellas Pharma US Inc$51
- plus $281 from 13 others
What the payments were for
- Food & beverage$948100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $323 |
| Abbott | 7 | $101 |
| Novartis | 4 | $68 |
| Amarin Pharma, Inc. | 4 | $63 |
| GSK | 4 | $61 |
| Astellas Pharma US Inc | 3 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Lilly USA, LLC | 3 | $40 |
| Boehringer Ingelheim | 2 | $30 |
| Eisai Inc. | 2 | $29 |
| Biohaven Pharmaceuticals, Inc. | 1 | $22 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Merck | 1 | $19 |
| Pfizer | 1 | $15 |
| Bayer | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| Ultragenyx Pharmaceutical Inc. | 1 | $11 |
How this compares
$948 in reported general payments places this provider in the 55th percentile of 2,087 family medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 20 | $9,404 |
| Fluconazole | 14 | $546 |
| Mupirocin | 11 | $167 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Livingston
- Kevin DennisFranklin$354K
- Charolette JacksonBartlett$162K
- Keren HolmesNashville$58K
- Kabir Harricharan SinghNewport$49K
- Khaisha GistAntioch$49K
- Jerry PunchKnoxville$45K
- Christopher HollowayAntioch$41K
- Curtis JantziKingsport$39K
- Ellen ClelandChattanooga$38K
- Meredith SchweitzerAntioch$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.